NCT01940393View on ClinicalTrials.gov

Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
Urticaria
Interventions
DRUG

Cetirizine

Drug administration

DRUG

Desloratadine

Drug Administration

DRUG

Fexofenadine

Drug administration

DRUG

Ebastine

Drug administration

DRUG

Bilastine

Drug administration

Trial Locations (1)

Unknown

Medellin, Medellín

All Listed Sponsors
lead

Grupo de Alergología Clínica y Experimental

OTHER

NCT01940393 - Evaluation of the Inhibitory Effect of 5 Anti-Histamines in Urticaria | Biotech Hunter | Biotech Hunter